Clinical utility of circulating tumor DNA (ctDNA) in patients with early/resected biliary tract cancer (BTC)

被引：0
|
作者：
Yu, J. [1 ]
Mehta, R. [1 ]
Anaya, D. [1 ]
Denbo, J. [1 ]
Bridges, C. [2 ]
Manage, K. [2 ]
Tin, A. [2 ]
Aushev, V. [2 ]
Sharma, S. [2 ]
Jurdi, A. [2 ]
Liu, M. [2 ]
Kim, R. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Natera Inc, San Carlos, CA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-116
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [1] Clinical utility of circulating tumor DNA (ctDNA) in advanced and metastatic breast cancer
    Austin, Laura K.
    Jaslow, Rebecca
    Avery, Tiffany
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
  • [2] Utilization of circulating tumor DNA (ctDNA) testing in biliary tract cancers.
    Naleid, Nikolas
    Pawar, Omkar
    Patell, Kanchi
    Conces, Madison
    Lumish, Melissa Amy
    Selfridge, J. Eva
    Mohamed, A. M. R.
    Bajor, David L.
    Chakrabarti, Sakti
    Mahipal, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 644 - 644
  • [3] Assessment of mutation burden after clinical intervention in pancreatic ductal adenocarcinomas (PDAC), and biliary tract cancers (BTC) via profiling circulating tumor DNA (ctDNA).
    Pittella-Silva, Fabio
    Motoya, Masayo
    Kimura, Yasutoshi
    Nakamura, Toru
    Low, Siew-Kee Kee
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Utility of circulating tumor DNA (ctDNA) to inform treatment of patients with metastatic breast cancer
    Linville, Laura Meili
    Canzoniero, Jenna VanLiere
    Too, Faith
    Lombardo, Alexandra
    Malwankar, Jui
    Mawalkar, Resham
    Haile, Meron
    Zandi, Lily
    Babu, Vidya
    Brown, Derek W.
    Xu, Chang
    Boyle, Patrick
    Pasquina, Lincoln W.
    Santa-Maria, Cesar Augusto
    Tao, Jessica
    Bayable, Asnakech
    Greenberg, Larisa
    Anagnostou, Valsamo
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Circulating Tumor DNA and Biliary Tract Cancer Diagnosis
    Sorscher, Steven
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 2
  • [6] Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Keane, Fergus
    Saadat, Lily
    O'Connor, Catherine
    Chou, Joanne F.
    Brannon, Angela Rose
    Cowzer, Darren
    Crowley, Fionnuala
    Debnath, Neha
    Bowman, Anita
    Xu, Fei
    Park, Wungki
    Zervoudakis, Alice
    Balogun, Fiyinfolu
    Varghese, Anna M.
    Yu, Kenneth H.
    Kelsen, David Paul
    Capanu, Marinela
    Berger, Michael F.
    Wei, Alice Chia-Chi
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer.
    Wang, Judy Sing-Zan
    Sausen, Mark
    Parpart-Li, Sonya
    Murphy, Derek M.
    Velculescu, Victor E.
    Wood, Laura D.
    Solt-Linville, Sara
    Sugar, Elizabeth
    Bartlett, Bjarne
    Blair, Cherie
    Dauses, Tianna
    Jaffee, Elizabeth M.
    Hruban, Ralph H.
    Laheru, Dan
    Diaz, Luis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Clinical utility of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)
    Lim, Yoojoo
    Kim, Sheehyun
    Kang, Jun-Kyu
    Kim, Hwang-Phil
    Roh, Hanseong
    Kim, Su Yeon
    Lee, Dongin
    Bang, Duhee
    Jeong, Seung-Yong
    Park, Kyu Joo
    Han, Sae-Won
    Kim, Tae-You
    ANNALS OF ONCOLOGY, 2022, 33 : S507 - S507
  • [9] Clinical application of circulating tumor DNA (ctDNA) in patients with metastatic gastric cancer.
    Hong, Moonki
    Lee, Kwang Seob
    Park, Sejung
    Kim, Kyoo Hyun
    Kim, Hyunwook
    Che, Jingmin
    Kwon, Woo Sun
    Lee, Choong-kun
    Jung, Minkyu
    Chung, Hyun Cheol Cheol
    Shin, Saeam
    Lee, Seung-Tae
    Choi, Jong Rak
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 441 - 441
  • [10] Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA).
    Diehn, Maximilian
    Alizadeh, Ash A.
    Adams, Hans-Peter
    Lee, John J.
    Klassen, Susanne
    Palma, John F.
    Hinzman, Bernd
    Lovejoy, Alexander F.
    Newman, Aaron M.
    Yao, Lijing
    Yaung, Stephanie
    Balasubramanyam, Aarthi
    Rohr, Ulrich Peter
    Rosenthal, Andre
    Kube, Rainer
    Steinmueller, Thomas
    Marusch, Frank
    Mantke, Rene
    Heise, Michael
    Pross, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345